156 related articles for article (PubMed ID: 9846334)
1. [Iatrogenic Creutzfeld-Jakob disease. Significance of cases observed after extracted growth hormone treatment].
Billette de Villemeur T
Rev Neurol (Paris); 1998 Oct; 154(10):651-2. PubMed ID: 9846334
[No Abstract] [Full Text] [Related]
2. [Iatrogenic Creutzfeld-Jakob disease induced by the administration of extracted growth hormone].
Rev Neurol (Paris); 1993; 149(10):515-6. PubMed ID: 8023062
[No Abstract] [Full Text] [Related]
3. [Creutzfeldt-Jakob disease in 4 children treated with growth hormone].
Billette de Villemeur T; Gourmelen M; Beauvais P; Rodriguez D; Vaudour G; Deslys JP; Dormont D; Richard P; Richardet JM
Rev Neurol (Paris); 1992; 148(5):328-34. PubMed ID: 1448646
[TBL] [Abstract][Full Text] [Related]
4. Iatrogenic Creutzfeldt-Jakob disease 22 years after human growth hormone therapy: clinical and radiological features.
Furtner M; Gelpi E; Kiechl S; Knoflach M; Zangerl A; Gotwald T; Willeit J; Maier H; Ströbel T; Unterberger U; Budka H
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):229-31. PubMed ID: 18202218
[No Abstract] [Full Text] [Related]
5. [Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study].
Delisle MB; Fabre N; Rochiccioli P; Doerr-Schott J; Rumeau JL; Bes A
Rev Neurol (Paris); 1993; 149(10):524-7. PubMed ID: 8023064
[TBL] [Abstract][Full Text] [Related]
6. [Hypophyseal growth hormone and Creutzfeldt-Jakob disease in The Netherlands. Ad hoc Commission Creutzfeldt-Jakob-disease of the Dutch Growth Foundation].
Rikken B; Massa GG; Wit JM; van den Brande JL
Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1163-5. PubMed ID: 8692348
[No Abstract] [Full Text] [Related]
7. [Treatment with extractive growth hormone and Creutzfeld-Jakob encephalopathy: a new iatrogenic tragedy].
Battin J
Pediatrie; 1993; 48(2):91-5. PubMed ID: 8393184
[No Abstract] [Full Text] [Related]
8. [Creutzfeld-Jakob disease].
Giraud P; Alpérovitch A; Chazot G
Rev Prat; 1999 May; 49(9):948-53. PubMed ID: 11865459
[TBL] [Abstract][Full Text] [Related]
9. Iatrogenic Creutzfeldt-Jakob disease following human growth hormone therapy: case report.
Caboclo LO; Huang N; Lepski GA; Livramento JA; Buchpiguel CA; Porto CS; Nitrini R
Arq Neuropsiquiatr; 2002 Jun; 60(2-B):458-61. PubMed ID: 12131950
[TBL] [Abstract][Full Text] [Related]
10. Creutzfeldt-Jakob disease 38 years after diagnostic use of human growth hormone.
Croes EA; Roks G; Jansen GH; Nijssen PC; van Duijn CM
J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):792-3. PubMed ID: 12023427
[TBL] [Abstract][Full Text] [Related]
11. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease--being aware of diagnostic features 25 years later.
Dixit K; Kreitschmann-Andermahr I; Basu A; Dick JP; Manoharan P; Shalet S; Brabant G
J Clin Endocrinol Metab; 2009 Aug; 94(8):2684-5. PubMed ID: 19657045
[No Abstract] [Full Text] [Related]
12. Serial EEG findings in sporadic and iatrogenic Creutzfeldt-Jakob disease.
Wieser HG; Schwarz U; Blättler T; Bernoulli C; Sitzler M; Stoeck K; Glatzel M
Clin Neurophysiol; 2004 Nov; 115(11):2467-78. PubMed ID: 15465434
[TBL] [Abstract][Full Text] [Related]
13. [Is there a causative relation between infectious degenerative encephalopathy and the use of growth hormone?].
Romer TE
Pediatr Pol; 1986 Nov; 61(11):740-4. PubMed ID: 3295737
[No Abstract] [Full Text] [Related]
14. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.
Noguchi-Shinohara M; Hamaguchi T; Kitamoto T; Sato T; Nakamura Y; Mizusawa H; Yamada M
Neurology; 2007 Jul; 69(4):360-7. PubMed ID: 17646628
[TBL] [Abstract][Full Text] [Related]
15. Creutzfeldt-Jakob disease:another avenue?
Williamson K
Br J Hosp Med; 1994 Jan 19-Feb 1; 51(1-2):7-8. PubMed ID: 8826036
[No Abstract] [Full Text] [Related]
16. Human growth hormone therapy and Creutzfeldt-Jakob disease: a drama in three acts.
Brown P
Pediatrics; 1988 Jan; 81(1):85-92. PubMed ID: 3275936
[No Abstract] [Full Text] [Related]
17. Iatrogenic Creutzfeldt-Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients?
Boyd A; Klug GM; Schonberger LB; McGlade A; Brandel JP; Masters CL; Collins SJ
Med J Aust; 2010 Sep; 193(6):366-9. PubMed ID: 20854243
[TBL] [Abstract][Full Text] [Related]
18. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging.
Lewis AM; Yu M; DeArmond SJ; Dillon WP; Miller BL; Geschwind MD
Arch Neurol; 2006 Feb; 63(2):288-90. PubMed ID: 16476821
[TBL] [Abstract][Full Text] [Related]
19. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era.
Brown P; Brandel JP; Preece M; Sato T
Neurology; 2006 Aug; 67(3):389-93. PubMed ID: 16855204
[TBL] [Abstract][Full Text] [Related]
20. [Creutzfeldt-Jakob disease after treatment with growth hormone: the point in July, 1998].
Brandel JP; Agid Y
Rev Neurol (Paris); 1998 Oct; 154(10):654-5. PubMed ID: 9846335
[No Abstract] [Full Text] [Related]
[Next] [New Search]
